________________________________________________________________________________________________________________________________

(C) NanoMiPu 2014 - Courtesy Prof. Martin HoffmannDiagnostic Microfluidics: Sample In – Results Out?

Disassembling liquid handling automation: An inside view on electrowetting in blood diagnostics and other microfluidic applications. Tecan’s current R&D in this field and crucial differences to competitors like Advanced Liquid Logics (Illumina), Nugen Technologies, Covaris, or Cytonix acquired by Life Technologies. Glass, silicone, plastics, or paper? What material is best for clinical microfluidics. Why not acoustic wave technology? Candid answers to probing questions by Marc N. Feiglin, Chief Technology Officer Life Sciences at Tecan* in the exclusive interview with B2Bioworld.

* Editor's Note: Marc Feiglin has left Tecan in November 2014. Since last June he heads Technology Acquisition for Cell Science in INTER-LAB Ltd. at Yavne (IL). INTER-LAB is part of Merck Serono Ltd. (Merck KGaA).

 

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 9 pages
- Includes technical information and pictures of inventions which allow independent comparisons

Full Company License enquire here

Back to section

Related Editorial Articles

Make or Break Drug Discovery and Biopharma of Merck Life Science
Andrew Bulpin, currently Global Head of Merck Millipore Process Solutions on strategy and the road ahead. Includes competitive rank of Merck Life Science Division

Transition Cancer Research Translation
Christof von Kalle, Head of National Center for Tumor Diseases at Heidelberg

Physics <> Information <> Biology
A view from quantum optics. Interview with Alain Aspect, Professor of Physics at Institut d’Optique and Balzan Prize winner

Metrics for Disease, Health, and Wellness
Personalized medicine? A systems look at human genetic diagnostics and the road ahead for next-generation sequencing by Leroy Hood, Institute for Systems Biology at Seattle

Custom Sequencing Markets
Worldwide evolution of the market and upcoming business opportunities

Laboratory Automation: Everyone Re-invents The Wheel
Michael Collasius, Vice President Automated Systems Qiagen NV, on industry-wide standards for laboratory instruments

Handling Suppliers of Mass Spectrometers Delicately
Michael P. Myers, Group Leader, Protein Networks at the International Centre for Genetic Engineering and Biotechnology, Trieste (IT) tells how he is avoiding to get trapped by manufacturers of mass spectrometers and their strategies to fend off competitors with proprietary data formats. 

Stem Cells: a discovery tool and a potential therapeutic modality
Dr Jonathan Knowles, former Member of the Roche Executive Committee and Head of Group Research. “Personalised medicine” revisited

The Myriad Way
Peter D Meldrum, CEO of the genetics company on battles about patents, cancer chips, and competitors in commercial academia

Close-up: National Center for Tumor Diseases Heidelberg
An independent and non-sponsored look by B2Bioworld Editors

Electrophoresis in Proteomics
Some Common Pitfalls and Ways to Avoid Them

Patient-centered Precision Care
Michael Christman, President of Coriell Institute about turning research on human genotyping into healthcare routine